title: Transplantation of kidneys from donors whose hearts have stopped beating.
abstract: BACKGROUND
  Attempts have recently been made to expand the number of cadaveric kidneys available for transplantation by using kidneys from donors without heartbeats in addition to those from brain-dead donors with beating hearts. We studied the efficacy of transplanting kidneys from donors without heartbeats on the basis of aggregate results from the Kidney Transplant Registry of the United Network for Organ Sharing.
  
  
  METHODS
  We compared the early function and survival rates of 229 kidney grafts from donors without heartbeats with those of 8718 grafts from cadaveric donors with heartbeats. All transplantations were performed at 64 U.S. transplantation centers. Cox proportional-hazards analysis was used to evaluate 10 major risk factors for graft failure.
  
  
  RESULTS
  The survival rate at one year was 83 percent for kidney grafts from donors without heartbeats, as compared with 86 percent for grafts from donors with heartbeats (P=0.26). Among the kidneys from donors without heartbeats, the survival rate at one year was 89 percent for grafts from donors who had died of trauma, as compared with 78 percent for grafts from donors who had died of other causes (P=0.04). The survival rates were high for grafts from donors without heartbeats despite the poorer early function of these grafts; 48 percent of the recipients required dialysis within the first week after transplantation, as compared with 22 percent of the recipients of grafts from donors with heartbeats. The primary-failure rate for kidneys from donors without heartbeats was 4 percent, as compared with 1 percent for kidneys from donors with heartbeats.
  
  
  CONCLUSIONS
  Transplantation of kidneys from donors whose hearts have stopped beating, especially those who have died of trauma, is often successful, and the use of kidneys from such donors could increase the overall supply of cadaveric kidney transplants.
authors.affiliation: Department of Surgery, University of California at Los Angeles School of Medicine, USA.
authors.forename: Y W
authors.initials: YW
authors.lastname: Cho
authors.forename: P I
authors.initials: PI
authors.lastname: Terasaki
authors.forename: J M
authors.initials: JM
authors.lastname: Cecka
authors.forename: D W
authors.initials: DW
authors.lastname: Gjertson
mesh_terms: D001926:Brain Death; D002102:Cadaver; D006085:Graft Survival; D006323:Heart Arrest; D006801:Humans; D016030:Kidney Transplantation; D016016:Proportional Hazards Models; D012307:Risk Factors; D015996:Survival Rate; D014019:Tissue Donors / Q000600:supply & distribution; D017211:Treatment Failure